Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;2(2):83-96.
doi: 10.1200/JGO.2015.000307. Epub 2015 Dec 23.

Creating a Global Community of Practice for Oncofertility

Affiliations

Creating a Global Community of Practice for Oncofertility

Lauren M Ataman et al. J Glob Oncol. 2016 Apr.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] JCO Glob Oncol. 2022 Mar;8:e2100417. doi: 10.1200/GO.21.00417. JCO Glob Oncol. 2022. PMID: 35275737 Free PMC article. No abstract available.

Corrected and republished in

  • Creating a Global Community of Practice for Oncofertility.
    Ataman LM, Rodrigues JK, Marinho RM, Caetano JPJ, Chehin MB, Alves da Motta EL, Serafini P, Suzuki N, Furui T, Takae S, Sugishita Y, Morishige KI, Almeida-Santos T, Melo C, Buzaglo K, Irwin K, Wallace WH, Anderson RA, Mitchell RT, Telfer EE, Adiga SK, Anazodo A, Stern C, Sullivan E, Jayasinghe Y, Orme L, Cohn R, McLachlan R, Deans R, Agresta F, Gerstl B, Ledger WL, Robker RL, de Meneses E Silva JM, Melo E Silva LHF, Lunardi FO, Lee JR, Suh CS, De Vos M, Van Moer E, Stoop D, Vloeberghs V, Smitz J, Tournaye H, Wildt L, Winkler-Crepaz K, Andersen CY, Smith BM, Smith K, Woodruff TK. Ataman LM, et al. JCO Glob Oncol. 2020 Nov;6:317-330. doi: 10.1200/GO.22.00007. JCO Glob Oncol. 2020. PMID: 35275745 Free PMC article.

Abstract

Fertility preservation in the cancer setting, known as oncofertility, is a field that requires cross-disciplinary interaction between physicians, basic scientists, clinical researchers, ethicists, lawyers, educators, and religious leaders. Funded by the National Institutes of Health, the Oncofertility Consortium (OC) was formed to be a scientifically grounded, transparent, and altruistic resource, both intellectual and monetary, for building this new field of practice capable of addressing the unique needs of young patients with cancer. The OC has expanded its attention to include other nonmalignant conditions that can threaten fertility, and the work of the OC now extends around the globe, involving partners who together have created a community of shared effort, resources, and practices. The OC creates materials that are translated, disseminated, and amended by all participants in the field, and local programs of excellence have developed worldwide to accelerate the pace and improve the quality of oncofertility research and practice. Here we review the global oncofertility programs and the capacity building activities that strengthen these research and clinical programs, ultimately improving patient care.

PubMed Disclaimer

Conflict of interest statement

Lauren Ataman

No relationship to disclose

Jhenifer Kl. Rodrigues

No relationship to disclose

Ricardo M. Marinho

No relationship to disclose

João P.J. Caetano

No relationship to disclose

Maurício B. Chehin

No relationship to disclose

Eduardo L. Alves da Motta

Stock or Other Ownership: Illumina

Paulo Serafini

No relationship to disclose

Nao Suzuki

No relationship to disclose

Tatsuro Furui

No relationship to disclose

Seido Takae

No relationship to disclose

Yodo Sugishita

No relationship to disclose

Ken-Ichiro Morishige

No relationship to disclose

Teresa Almeida-Santos

No relationship to disclose

Cláudia Melo

Speakers' Bureau: Merck Serono

Karen Buzaglo

Travel, Accommodations, Expenses: EMD Serono

Karen Irwin

No relationship to disclose

W. Hamish Wallace

No relationship to disclose

Richard Anderson

Honoraria: Beckman Coulter, Roche Diagnostics

Research Funding: Roche Diagnostics

Roderick T. Mitchell

No relationship to disclose

Evelyn E. Telfer

Patents, Royalties, Other Intellectual Property: Method for in vitro growth

Satish K. Adiga

No relationship to disclose

Antoinette Anazodo

No relationship to disclose

Catharyn Stern

Employment: Virtus Health

Stock or Other Ownership: Virtus Health

Research Funding: Merck-Serono (Inst)

Elizabeth Sullivan

No relationship to disclose

Yasmin Jayasinghe

No relationship to disclose

Richard Cohn

No relationship to disclose

Rob McLachlan

Stock or Other Ownership: Monash IVF Group

Consulting or Advisory Role: Monash IVF Group

Rebecca Deans

No relationship to disclose

Franca Agresta

Employment: Melbourne IVF, CSL Behring (I)

Stock or Other Ownership: Melbourne IVF, CSL Behring (I)

Research Funding: Ferring (Inst), Merck-Serono (Inst)

Travel, Accommodations, Expenses: Ferring

Brigitte Gerstl

No relationship to disclose

William L. Ledger

Employment: IVF Australia

Leadership: IVF Australia

Honoraria: MSD, Ferring Pharmaceuticals, Merch Serono

Research Funding: MSD

Travel, Accommodations, Expenses: MSD, Ferring Pharmaceuticals

Rebecca Robker

No relationship to disclose

João M. de Meneses e Silva

No relationship to disclose

Lígia H.F. Melo e Silva

No relationship to disclose

Franciele O. Lunardi

No relationship to disclose

Jung R. Lee

No relationship to disclose

Chang S. Suh

No relationship to disclose

Michael De Vos

Honoraria: Cook Medical

Research Funding: Cook Medical (Inst)

Travel, Accommodations, Expenses: Cook Medical

Ellen Van Moer

No relationship to disclose

Dominic Stoop

No relationship to disclose

Veerle Vloeberghs

No relationship to disclose

Johan Smitz

No relationship to disclose

Herman Tournaye

Employment: In2Pharma (I)

Honoraria: Abbott Laboratories

Consulting or Advisory Role: Finox, OvaScience

Research Funding: Ferring (Inst), Cook Medical (Inst), MSD (Inst), Merck Serono (Inst), Goodlife (Inst), Abbott Laboratories (Inst), ObsEva (Inst)

Travel, Accommodations, Expenses: Ferring Pharmaceuticals, MSD

Ludwig Wildt

No relationship to disclose

Katharina Winkler-Crepaz

No relationship to disclose

Claus Y. Anderson

No relationship to disclose

Brigid M. Smith

No relationship to disclose

Kristin Smith

No relationship to disclose

Teresa K. Woodruff

No relationship to disclose

Figures

Figure 1
Figure 1
Map of countries (purple) represented in Oncofertility Consortium global partners network.
Figure 2
Figure 2
Flow chart: becoming global partner. OC, Oncofertility Consortium.
Figure 3
Figure 3
Oncofertility Consortium global partnerships model.
Figure 4
Figure 4
Brazilian Oncofertility Consortium.
Figure 5
Figure 5
Japan Society for Fertility Preservation.
Figure 6
Figure 6
Portuguese Centre for Fertility Preservation.
Figure 7
Figure 7
Korea National Fertility Preservation Network.

References

    1. Lower death rates & more survivors, in National Cancer Institute. Building on Opportunities in Cancer Research. http://www.cancer.gov/about-nci/budget/annual-plan/nci-plan-2016.pdf .
    1. Woodruff TK. From the bench to bedside to babies: Translational medicine made possible by funding multidisciplinary team science. J Assist Reprod Genet. 2013;30:1249–1253. - PMC - PubMed
    1. Woodruff TK, KS. Synder, Oncofertility. New York, NY: Springer; 2007.
    1. Woodruff TK, Clayman ML, Waimey KE. Oncofertility Communication: Sharing Information and Building Relationships Across Disciplines. New York, NY: Springer; 2013.
    1. Woodruff TK, Gracia C. Oncofertility: Clinical Issues and Implementation. New York, NY: Springer; 2012.

LinkOut - more resources